A perspective on COVID-19 hospitalised patients across Europe:
data from the ENDCOVID CRC

a 2024

A perspective on COVID-19 hospitalised patients across Europe: data from the ENDCOVID CRC

NIGRO, Mattia; Claudia VALENZUELA; Marko LUCIJANIC; Vladimir KOBLIZEK; Rosario MENENDEZ et. al.

Základní údaje

Originální název

A perspective on COVID-19 hospitalised patients across Europe: data from the ENDCOVID CRC

Autoři

Vydání

ERS Congress 2024 7.-11.9.2024 Vienna, 2024

Další údaje

Jazyk

angličtina

Typ výsledku

Konferenční abstrakt

Obor

30230 Other clinical medicine subjects

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL URL

Impakt faktor

Impact factor: 17.000 v roce 2023

Kód RIV

RIV/00216224:90034/24:00138354

Organizační jednotka

CZECRIN

ISSN

DOI

http://dx.doi.org/10.1183/13993003.congress-2024.PA1511

UT WoS

001356223600071

Klíčová slova česky

COVID-19; END-COVID clinical research; registries

Klíčová slova anglicky

COVID-19; END-COVID clinical research; registries

Štítky

Abstrakt, FN HK, Klinické hodnocení, RIV, user

Příznaky

Mezinárodní význam

Změněno: 27. 2. 2025 10:05, Bc. Hana Vladíková, BBA

Anotace

V originále

The COVID-19 pandemic has represented a relevant burden on European healthcare systems in the past few years. Differences in the hospitalised population features, treatment regimens and outcomes across European Countries are expected. An international, multicentric, observational, cross-sectional study has been conducted by the END-COVID clinical research collaboration through the creation of a federation of registries enrolling hospitalised COVID-19 patients at local or national level. Data sharing was achieved only through median [IQR] and absolute numbers (%) of relevant variables, with no individual participant data dissemination. 11 registries from 8 different countries enrolling a total of 19,461 patients have been included in the analysis. All patients had a confirmed SARS-CoV-2 infection. The median age ranged between 56 (Romania) and 80 years (Italy), while male patients ranged from 51.2% (Ireland) to 65.7% (Netherlands). The proportion of patients achieving the diagnosis with a PCR nasal swab test ranged between 69.8% (Czech Republic) and 100.0% (Italy, Netherlands, and Ireland). Southern European centres used both systemic antibiotics (56.0% vs 68.3% vs 74.3%, P < 0.0001) and systemic corticosteroids (40.4% vs 61.1% vs 64.4%, P < 0.0001) less frequently than Northern and Eastern European ones. Access to Intensive Care Unit was less common in Southern European centres compared to Northern and Eastern European centres (10.1% vs 21.5% vs 22.7%, P < 0.0001). In-hospital mortality ranged between 5.7% (Spain) and 33.9% (Croatia). We highlighted substantial differences in the population features, treatment regimens and outcomes of COVID-19 hospitalised patients across Europe.

Návaznosti

90249, velká výzkumná infrastruktura

Název: CZECRIN IV

Citovat

NIGRO, Mattia; Claudia VALENZUELA; Marko LUCIJANIC; Vladimir KOBLIZEK; Rosario MENENDEZ; Alessandra BANDERA; Raffaele ANTONELLI-INCALZI; Cormac MCCARTHY; Merel HELLEMONS; Philippe LAMBIN; Branislava MILENKOVIC; Sara TOMASSETTI; Florin MIHALTAN; James CHALMERS a Stefano ALIBERTI. A perspective on COVID-19 hospitalised patients across Europe: data from the ENDCOVID CRC. In ERS Congress 2024 7.-11.9.2024 Vienna. 2024. ISSN 0903-1936. Dostupné z: https://dx.doi.org/10.1183/13993003.congress-2024.PA1511.

@proceedings{2465962,
   author = {Nigro, Mattia and Valenzuela, Claudia and Lucijanic, Marko and Koblizek, Vladimir and Menendez, Rosario and Bandera, Alessandra and AntonelliandIncalzi, Raffaele and Mccarthy, Cormac and Hellemons, Merel and Lambin, Philippe and Milenkovic, Branislava and Tomassetti, Sara and Mihaltan, Florin and Chalmers, James and Aliberti, Stefano},
   booktitle = {ERS Congress 2024 7.-11.9.2024 Vienna},
   doi = {http://dx.doi.org/10.1183/13993003.congress-2024.PA1511},
   keywords = {COVID-19; END-COVID clinical research; registries},
   language = {eng},
   title = {A perspective on COVID-19 hospitalised patients across Europe: data from the ENDCOVID CRC},
   url = {https://www.ersnet.org/wp-content/uploads/2024/09/Congress-Programme-2024-0409.pdf},
   year = {2024}
}

TY  - CONF
ID  - 2465962
AU  - Nigro, Mattia - Valenzuela, Claudia - Lucijanic, Marko - Koblizek, Vladimir - Menendez, Rosario - Bandera, Alessandra - Antonelli-Incalzi, Raffaele - Mccarthy, Cormac - Hellemons, Merel - Lambin, Philippe - Milenkovic, Branislava - Tomassetti, Sara - Mihaltan, Florin - Chalmers, James - Aliberti, Stefano
PY  - 2024
TI  - A perspective on COVID-19 hospitalised patients across Europe: data from the ENDCOVID CRC
KW  - COVID-19
KW  - END-COVID clinical research
KW  - registries
UR  - https://www.ersnet.org/wp-content/uploads/2024/09/Congress-Programme-2024-0409.pdf
N2  - The COVID-19 pandemic has represented a relevant burden on European healthcare systems in the past few years. Differences in the hospitalised population features, treatment regimens and outcomes across European Countries are expected. An international, multicentric, observational, cross-sectional study has been conducted by the END-COVID clinical research collaboration through the creation of a federation of registries enrolling hospitalised COVID-19 patients at local or national level. Data sharing was achieved only through median [IQR] and absolute numbers (%) of relevant variables, with no individual participant data dissemination. 11 registries from 8 different countries enrolling a total of 19,461 patients have been included in the analysis. All patients had a confirmed SARS-CoV-2 infection. The median age ranged between 56 (Romania) and 80 years (Italy), while male patients ranged from 51.2% (Ireland) to 65.7% (Netherlands). The proportion of patients achieving the diagnosis with a PCR nasal swab test ranged between 69.8% (Czech Republic) and 100.0% (Italy, Netherlands, and Ireland). Southern European centres used both systemic antibiotics (56.0% vs 68.3% vs 74.3%, P < 0.0001) and systemic corticosteroids (40.4% vs 61.1% vs 64.4%, P < 0.0001) less frequently than Northern and Eastern European ones. Access to Intensive Care Unit was less common in Southern European centres compared to Northern and Eastern European centres (10.1% vs 21.5% vs 22.7%, P < 0.0001). In-hospital mortality ranged between 5.7% (Spain) and 33.9% (Croatia). We highlighted substantial differences in the population features, treatment regimens and outcomes of COVID-19 hospitalised patients across Europe.
ER  -

NIGRO, Mattia; Claudia VALENZUELA; Marko LUCIJANIC; Vladimir KOBLIZEK; Rosario MENENDEZ; Alessandra BANDERA; Raffaele ANTONELLI-INCALZI; Cormac MCCARTHY; Merel HELLEMONS; Philippe LAMBIN; Branislava MILENKOVIC; Sara TOMASSETTI; Florin MIHALTAN; James CHALMERS a Stefano ALIBERTI. A perspective on COVID-19 hospitalised patients across Europe: data from the ENDCOVID CRC. In \textit{ERS Congress 2024 7.-11.9.2024 Vienna}. 2024. ISSN~0903-1936. Dostupné z: https://dx.doi.org/10.1183/13993003.congress-2024.PA1511.

Přehled o publikaci